{
    "directory": "data/tmp",
    "company": "CRISPR Therapeutics",
    "unicorn_year": "2016",
    "industry": "Healthcare",
    "company_description": "Gene editing platform to develop medicines for rare and common diseases",
    "founders": "",
    "number_of_founders": "4",
    "year_founded": "2013",
    "yrs_to_unicorn": "3",
    "hq": "",
    "female": "1",
    "gen_immigrant": "0",
    "immigrant": "1",
    "heritage": "Canadian",
    "ethnicity": "White",
    "graduation_year": "1991",
    "age_@_unicorn": "47",
    "seed_investors": "n/a",
    "solo_founder": "0",
    "serial_founder": "0",
    "stem": "1",
    "degree_studied": "Microbiology",
    "stem_ceo": "1",
    "universities": "Pierre and Marie Curie Uni, British Columbia, Phillip University of Marburg",
    "description": "",
    "embedding_text": "Gene editing platform to develop medicines for rare and common diseases"
}